• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SPARC 基因启动子甲基化及其在胰腺癌中的临床意义。

Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer.

机构信息

Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.

出版信息

J Exp Clin Cancer Res. 2010 Mar 26;29(1):28. doi: 10.1186/1756-9966-29-28.

DOI:10.1186/1756-9966-29-28
PMID:20338068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2862018/
Abstract

BACKGROUND

The secreted protein acidic and rich in cysteine (SPARC) plays a pivotal role in regulating cell-matrix interactions and tumor angiogenesis, proliferation, and migration. Detection of SPARC gene methylation may be useful as a tumorigenesis marker for early detection of pancreatic cancer.

METHODS

Methylation of the SPARC gene transcriptional regulation region (TRR) was detected using bisulfite-specific (BSP) PCR-based sequencing analysis in 40 cases of pancreatic cancer and the adjacent normal tissues, 6 chronic pancreatitis tissues, and 6 normal pancreatic tissues. BSP cloning-based sequencing analysis was also performed in selected cases. Clinicopathological data from the cancer patients were collected and analyzed.

RESULTS

Analysis of SPARC gene TRR methylation showed two hypermethylation wave peak regions: CpG Region 1 (CpG site 1-7) and CpG Region 2 (CpG site 8-12). Pancreatic tissues have shown methylation in both regions with gradual increases from normal, chronic pancreatitis, and adjacent normal tissues to cancerous tissues. However, Methylation of CpG Region 2 was more sensitive than CpG Region 1 in pancreatic tumorigenesis. Furthermore, the methylation level of CpG Region 2 was associated with increased tumor size and exposure to the risk factors (tobacco smoke and alcohol consumption) for developing pancreatic cancer.

CONCLUSION

Methylation of the SPARC gene, specifically CpG Region 2, may be an early event during pancreatic tumorigenesis and should be further evaluated as a tumorigenesis marker for early detection of pancreatic cancer.

摘要

背景

富含半胱氨酸的酸性分泌蛋白(SPARC)在调节细胞-基质相互作用以及肿瘤血管生成、增殖和迁移方面发挥着关键作用。检测 SPARC 基因甲基化可能有助于作为胰腺癌早期检测的肿瘤发生标志物。

方法

采用亚硫酸氢盐特异性(BSP)PCR 测序分析方法检测 40 例胰腺癌及其相邻正常组织、6 例慢性胰腺炎组织和 6 例正常胰腺组织中 SPARC 基因转录调控区(TRR)的甲基化情况。在选定的病例中还进行了 BSP 克隆测序分析。收集并分析了癌症患者的临床病理资料。

结果

对 SPARC 基因 TRR 甲基化的分析显示出两个高甲基化波峰区域:CpG 区域 1(CpG 位点 1-7)和 CpG 区域 2(CpG 位点 8-12)。胰腺组织在两个区域均显示出甲基化,其甲基化程度从正常组织、慢性胰腺炎组织和相邻正常组织逐渐增加到癌组织。然而,CpG 区域 2 的甲基化比 CpG 区域 1 在胰腺肿瘤发生中更为敏感。此外,CpG 区域 2 的甲基化水平与肿瘤大小的增加以及患胰腺癌的危险因素(吸烟和饮酒)暴露有关。

结论

SPARC 基因的甲基化,特别是 CpG 区域 2,可能是胰腺肿瘤发生的早期事件,应进一步作为胰腺癌早期检测的肿瘤发生标志物进行评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961f/2862018/c594c3dda90b/1756-9966-29-28-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961f/2862018/f0a795bfae9a/1756-9966-29-28-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961f/2862018/646b49f6f8e2/1756-9966-29-28-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961f/2862018/0fbd2e00e385/1756-9966-29-28-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961f/2862018/c594c3dda90b/1756-9966-29-28-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961f/2862018/f0a795bfae9a/1756-9966-29-28-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961f/2862018/646b49f6f8e2/1756-9966-29-28-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961f/2862018/0fbd2e00e385/1756-9966-29-28-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961f/2862018/c594c3dda90b/1756-9966-29-28-4.jpg

相似文献

1
Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer.SPARC 基因启动子甲基化及其在胰腺癌中的临床意义。
J Exp Clin Cancer Res. 2010 Mar 26;29(1):28. doi: 10.1186/1756-9966-29-28.
2
Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.胰腺癌患者循环 DNA 中肿瘤抑制基因启动子甲基化状态的临床意义。
J Cancer Res Clin Oncol. 2020 Apr;146(4):897-907. doi: 10.1007/s00432-020-03169-y. Epub 2020 Mar 7.
3
Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.在结肠癌中,SPARC常因启动子高甲基化而失活。
Int J Cancer. 2007 Aug 1;121(3):567-75. doi: 10.1002/ijc.22706.
4
Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.在子宫内膜癌中,富含CpG区域的SPARC异常高甲基化导致其转录沉默,而SPARC蛋白却过表达,二者形成鲜明对比。
Oncol Rep. 2007 Jun;17(6):1301-7.
5
SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.富含半胱氨酸的酸性分泌蛋白/骨连接蛋白是胰腺腺癌中异常甲基化的常见靶点,也是肿瘤-基质相互作用的介质。
Oncogene. 2003 Aug 7;22(32):5021-30. doi: 10.1038/sj.onc.1206807.
6
Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.结直肠癌的淋巴管血管侵犯与肿瘤基质微环境中 SPARC 的表达相关。
Epigenetics. 2011 Aug;6(8):1001-11. doi: 10.4161/epi.6.8.16063. Epub 2011 Aug 1.
7
Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.胰腺腺癌中甲基化启动子的全基因组分析
Cancer Biol Ther. 2008 Jul;7(7):1146-56. doi: 10.4161/cbt.7.7.6208. Epub 2008 Apr 29.
8
Hypermethylation of the SPARC promoter and its prognostic value for prostate cancer.SPARC 启动子的高甲基化及其对前列腺癌的预后价值。
Oncol Rep. 2018 Feb;39(2):659-666. doi: 10.3892/or.2017.6121. Epub 2017 Nov 29.
9
Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.SPARC基因启动子的异常甲基化及其在胃癌中的临床意义。
Sci Rep. 2014 Dec 17;4:7035. doi: 10.1038/srep07035.
10
Aberrant methylation of secreted protein acidic and rich in cysteine gene and its significance in gastric cancer.分泌型卷曲相关蛋白 2 基因异常甲基化及其在胃癌中的意义
World J Gastroenterol. 2019 Dec 14;25(46):6713-6727. doi: 10.3748/wjg.v25.i46.6713.

引用本文的文献

1
Design and experimental validation of OPERA_MET-A panel for deep methylation analysis by next generation sequencing.用于下一代测序深度甲基化分析的OPERA_MET-A面板的设计与实验验证
Front Oncol. 2022 Aug 11;12:968804. doi: 10.3389/fonc.2022.968804. eCollection 2022.
2
Potential Prognostic Role of Methylation in Non-Small-Cell Lung Cancer.甲基化在非小细胞肺癌中的潜在预后作用。
Cells. 2020 Jun 22;9(6):1523. doi: 10.3390/cells9061523.
3
Osteonectin as a screening marker for pancreatic cancer: A prospective study.骨连接素作为胰腺癌的筛查标志物:一项前瞻性研究。

本文引用的文献

1
Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression.内源性 SPARC 的抑制增强了胰腺癌细胞的生长:由 FGFR1-III 异构体表达的调节。
Br J Cancer. 2010 Jan 5;102(1):188-95. doi: 10.1038/sj.bjc.6605440. Epub 2009 Nov 17.
2
Field effect in cancer-an update.癌症中的场效应——最新进展
Ann Clin Lab Sci. 2009 Fall;39(4):331-7.
3
Epidemiology of pancreatic cancer: an overview.胰腺癌的流行病学:概述。
J Int Med Res. 2018 Jul;46(7):2769-2779. doi: 10.1177/0300060518772413. Epub 2018 May 13.
4
Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options.晚期胰腺导管腺癌——治疗的复杂性及新出现的治疗选择
World J Gastroenterol. 2017 Apr 7;23(13):2276-2285. doi: 10.3748/wjg.v23.i13.2276.
5
Drug metabolism and pancreatic cancer.药物代谢与胰腺癌
Ann Gastroenterol. 2017;30(1):54-61. doi: 10.20524/aog.2016.0074. Epub 2016 Jul 21.
6
A holistic approach to dissecting SPARC family protein complexity reveals FSTL-1 as an inhibitor of pancreatic cancer cell growth.整体方法剖析 SPARC 家族蛋白的复杂性揭示 FSTL-1 是一种胰腺癌细胞生长的抑制剂。
Sci Rep. 2016 Nov 25;6:37839. doi: 10.1038/srep37839.
7
Genetic factors affecting patient responses to pancreatic cancer treatment.影响患者对胰腺癌治疗反应的遗传因素。
Ann Gastroenterol. 2016 Oct-Dec;29(4):466-476. doi: 10.20524/aog.2016.0056. Epub 2016 Jun 10.
8
Roles of SPARC in urothelial carcinogenesis, progression and metastasis.富含半胱氨酸的酸性分泌蛋白(SPARC)在尿路上皮癌发生、进展和转移中的作用。
Oncotarget. 2016 Oct 11;7(41):67574-67585. doi: 10.18632/oncotarget.11590.
9
Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.基因组分析指导胰腺癌分子靶向治疗的选择。
Cancer Lett. 2015 Jul 10;363(1):1-6. doi: 10.1016/j.canlet.2015.04.009. Epub 2015 Apr 15.
10
SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.SIBLINGs和SPARC家族:它们在胰腺癌中日益凸显的作用
World J Gastroenterol. 2014 Oct 28;20(40):14747-59. doi: 10.3748/wjg.v20.i40.14747.
Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):699-708. doi: 10.1038/nrgastro.2009.177. Epub 2009 Oct 6.
4
The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers.非癌性食管黏膜中异常DNA甲基化与吸烟史的关系:食管癌风险诊断与预防的靶点
Cancer. 2009 Aug 1;115(15):3412-26. doi: 10.1002/cncr.24394.
5
Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer.DNA甲基转移酶-1和组蛋白去乙酰化酶-1在胰腺癌中的意义。
Oncol Rep. 2009 Jun;21(6):1439-47. doi: 10.3892/or_00000372.
6
Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis.胰腺癌术后辅助治疗的益处:一项基于人群的分析。
Cancer. 2009 Jun 1;115(11):2420-9. doi: 10.1002/cncr.24269.
7
Aberrant promoter methylation of SPARC in ovarian cancer.卵巢癌中SPARC基因启动子的异常甲基化
Neoplasia. 2009 Feb;11(2):126-35. doi: 10.1593/neo.81146.
8
Genetic and epigenetic alterations of familial pancreatic cancers.家族性胰腺癌的基因和表观遗传改变。
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3536-42. doi: 10.1158/1055-9965.EPI-08-0630.
9
Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer.检测胰腺癌中基于通路的基因-基因和基因-环境相互作用。
Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1470-9. doi: 10.1158/1055-9965.EPI-07-2797.
10
The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.基质细胞蛋白SPARC在肿瘤与宿主之间动态相互作用中的作用。
Cancer Metastasis Rev. 2008 Dec;27(4):691-705. doi: 10.1007/s10555-008-9146-7.